Sidley Updates

Securities Class Actions in the Life Sciences Sector

Spring 2020

Sidley is pleased to present its annual year-in-review addressing developments in securities class actions brought against life sciences companies in 2019.

In this publication, we provide an overview and analysis of trends in decisions involving life sciences companies with products at two distinct stages of development—pre- and post-FDA approval. We also summarize each of the reported federal decisions in this area and catalog the new securities class action complaints filed against life sciences companies in 2019.

Click here to view a two-page summary.

Click here to download the PDF.

Click here to order hard copies. Limited supply available.

View Survey View Two-Page Summary

律师广告—Sidley Austin LLP 是一家全球性律师事务所。我们的地址及联系方式可在 www.sidley.com/en/locations/offices 查阅。

Sidley 提供本信息仅作为向客户及其他友好人士提供的服务，且仅供教育目的使用。本信息不应被解释或依赖为法律意见，亦不构成律师与客户关系。读者在未寻求专业顾问意见之前，不应依据本信息采取任何行动。Sidley 和 Sidley Austin 指 Sidley Austin LLP 及其关联合伙实体，详见 www.sidley.com/disclaimer。

© Sidley Austin LLP